President & CEO
PhD, Assoc. Prof.
Fredrik Tiberg serves as President & CEO of Camurus since 2003. Camurus is a Swedish research-based pharmaceutical company committed to the development of innovative medicines for chronic and severe diseases.
Dr. Tiberg received his MSc (Chemical Engineering) from Lund Institute of Technology, and his PhD in Physical Chemistry from Lund University. He was appointed Professor in Physical Chemistry at Lund University in 1999, a position he held until 2017. During 2001-2002 he was Visiting Professor at the Physical and Theoretical Chemistry Laboratory, Oxford University. His research interests span from biophysical chemistry and advanced materials to clinical research.
He has published more than 100 original scientific papers, co-authored several books, and is named inventor on more than 300 issued patents. Fredrik is a member of the Royal Swedish Academy of Engineering Sciences (IVA).